Linezolid: some advantages over vancomycin in MRS

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1289, 2001-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Linezolid: some advantages over vancomycin in MRS

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 314, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Dalbavancin equivalent to linezolid, cefazolin, vancomycin for SSTI

By  

Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Linezolid/vancomycin: Development of linezolid- and vancomycin-resistance in Enterococcus faecium: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1224, 2008-01 ,pp. : 18-19

Adis International

Access to resources Recommend Favorite

IV vancomycin to oral linezolid switch potentially cost saving

By  

Inpharma, Vol. 1, Iss. 1400, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

IV vancomycin to oral linezolid switch potentially cost saving

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 425, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite